-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
June 16, 2010 - In advanced stages of
hematological malignancies bone marrow involvement with malignant cells often … endogenous
erythropoietin synthesis, suppressed differentiation of erythroid precursor cells in the
bone … Patients with myelodysplastic syndrome
or patients with acute leukemia who have anemia due to bone marrow … Studies of high-dose myeloablative
chemotherapy regimens followed by bone
marrow or peripheral blood
-
effectivehealthcare.ahrq.gov/products/osteoporosis-fracture-prevention/research
-
effectivehealthcare.ahrq.gov/products/vitamin-d-calcium/research-protocol
-
effectivehealthcare.ahrq.gov/products/breast-cancer-imaging/technical-brief
-
effectivehealthcare.ahrq.gov/products/osteoporosis-vibration-therapy/technical-brief
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
August 01, 2012 - events such as neurological adverse effects,
hypotension, rash, suicidal ideation, mood and cognition, bone … SCEPC
medications for hypotension, asthenia, ataxia,
nystagmus, tremor, mood and cognition, or bone … events such as
neurological adverse effects, hypotension, rash, suicidal ideation, mood and cognition, bone … events such as neurological adverse effects,
hypotension, rash, suicidal ideation, mood and cognition, bone … antiepileptic
medications for hypotension, asthenia, ataxia, nystagmus,
tremor, mood and cognition, or bone
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
August 01, 2012 - events such as neurological adverse effects,
hypotension, rash, suicidal ideation, mood and cognition, bone … SCEPC
medications for hypotension, asthenia, ataxia,
nystagmus, tremor, mood and cognition, or bone … events such as
neurological adverse effects, hypotension, rash, suicidal ideation, mood and cognition, bone … events such as neurological adverse effects,
hypotension, rash, suicidal ideation, mood and cognition, bone … antiepileptic
medications for hypotension, asthenia, ataxia, nystagmus,
tremor, mood and cognition, or bone
-
effectivehealthcare.ahrq.gov/health-topics/dislocations
-
effectivehealthcare.ahrq.gov/health-topics/marfan-syndrome
-
effectivehealthcare.ahrq.gov/health-topics/joint-disorders
-
effectivehealthcare.ahrq.gov/products/breast-cancer-imaging/research-protocol
-
effectivehealthcare.ahrq.gov/products/osteoarthritis-knee-update/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/prostate-cancer-therapies-summary.pdf
September 01, 2020 - radiographic and PSA results in
asymptomatic patients rather than as patient-reported outcomes (e.g., bone
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol-amendment.pdf
February 05, 2025 - hip adj3 (coxarthrosis or degenerative or dislocat* or
dysplasia or osteoarthritis)).ti,ab,kf.
16 bone … density/ or exp Bone Diseases, Metabolic/ or frailty/ or exp Osteoporosis/ or (bone
adj3 (density or
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol.pdf
July 09, 2024 - hip adj3 (coxarthrosis or degenerative or dislocat* or
dysplasia or osteoarthritis)).ti,ab,kf.
16 bone … density/ or exp Bone Diseases, Metabolic/ or frailty/ or exp Osteoporosis/ or (bone
adj3 (density or
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lysosomal-storage-diseases-therapies_disposition-comments.pdf
January 01, 2014 - Findings Page
12 Table 2
Gaucher
In the Gaucher disease section of the table, the bullet point "bone … "bone disease" and
then "significant hepatomegaly or splenomegaly"
Done. … The effect of
enzyme replacement therapy on bone crisis and bone pain in
patients with type 1 Gaucher … crisis, 244
patients with GD type 1 with bone pain, and 2153 patients with GD
type 1 enrolled in the … J Bone Miner Res 2007;22:119-26.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-disposition-120516.pdf
October 01, 2011 - Cartilage volume and bone marrow lesions were
assessed by MRI at baseline, 6, and 12 months
and synovial … Significantly
lower bone marrow lesions scores were found for
the chondroitin sulphate group at 12 … months in
the lateral compartment (p=0.035) and the lateral
femoral condyle (p=0.044). … 6 months into treatment and on cartilage
lesions combined with a protective effect on
subchondral bone … Chondroitin sulfate reduces both
cartilage volume loss and bone marrow lesions in
knee OA patients
-
effectivehealthcare.ahrq.gov/products/back-pain-imaging/clinician
-
effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_media_wilkes.ppt
April 01, 2006 - claimed it could prevent 2 million cases of breast cancer.
raloxifene is already used to prevent bone
-
effectivehealthcare.ahrq.gov/health-topics/craniofacial-abnormalities